Literature DB >> 17003394

Risk of death associated with nesiritide in patients with acutely decompensated heart failure.

Keith D Aaronson, Jonathan Sackner-Bernstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003394     DOI: 10.1001/jama.296.12.1465

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

Review 1.  Nesiritide for acute decompensated heart failure: does the benefit justify the risk?

Authors:  Jonathan Sackner-Bernstein; Keith D Aaronson
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

Review 2.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.

Authors:  Catherine Marti; Robert Cole; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2012-03

4.  KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways.

Authors:  Jwu-Lai Yeh; Jong-Hau Hsu; Ping-Ju Wu; Shu-Fen Liou; Chung-Pin Liu; Ing-Jun Chen; Bin-Nan Wu; Zen-Kong Dai; Jiunn-Ren Wu
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

Review 5.  circRNA is a potential target for cardiovascular diseases treatment.

Authors:  Jie Ju; Ya-Nan Song; Xin-Zhe Chen; Tao Wang; Cui-Yun Liu; Kun Wang
Journal:  Mol Cell Biochem       Date:  2021-11-15       Impact factor: 3.396

Review 6.  Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management.

Authors:  Paul F Kantor; Luc L Mertens
Journal:  Eur J Pediatr       Date:  2009-08-26       Impact factor: 3.183

Review 7.  Cardiorenal syndrome in heart failure: a cardiologist's perspective.

Authors:  Peter P Liu
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

Review 8.  Cardioprotective actions of peptide hormones in myocardial ischemia.

Authors:  Dwaine S Burley; Shabaz A Hamid; Gary F Baxter
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Authors:  Gad Cotter; Beth A Davison; Javed Butler; Sean P Collins; Justin A Ezekowitz; G Michael Felker; Gerasimos Filippatos; Phillip D Levy; Marco Metra; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Stefanie Senger; David Bharucha; Kathleen Goin; David G Soergel; Peter S Pang
Journal:  Clin Res Cardiol       Date:  2017-10-06       Impact factor: 5.460

Review 10.  Natriuretic peptides and therapeutic applications.

Authors:  Candace Y W Lee; John C Burnett
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.